BCLPX
Price
$8.67
Change
-$0.03 (-0.34%)
Updated
Jun 2 closing price
Net Assets
4.78B
WCFRX
Price
$11.17
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
83.46M
Interact to see
Advertisement

BCLPX vs WCFRX

Header iconBCLPX vs WCFRX Comparison
Open Charts BCLPX vs WCFRXBanner chart's image
BCLPX vs WCFRX Comparison Chart in %
View a ticker or compare two or three
VS
BCLPX vs. WCFRX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCLPX is a Buy and WCFRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BCLPX has more cash in the bank: 4.78B vs. WCFRX (83.5M). WCFRX pays higher dividends than BCLPX: WCFRX (6.55) vs BCLPX (3.07). BCLPX was incepted earlier than WCFRX: BCLPX (18 years) vs WCFRX (8 years). BCLPX (2.36) is less costly to investors than WCFRX (1.66). WCFRX is a more actively managed with annual turnover of: 126.00 vs. BCLPX (81.00). BCLPX has a lower initial minimum investment than WCFRX: BCLPX (1000) vs WCFRX (2500). BCLPX annual gain was more profitable for investors over the last year : 3.88 vs. WCFRX (2.79). BCLPX return over 5 years is better than : 6.02 vs. WCFRX (4.14).
BCLPXWCFRXBCLPX / WCFRX
Total Expense Ratio2.271.66137%
Annual Report Gross Expense Ratio2.361.66142%
Fund Existence18 years8 years-
Gain YTD1.2811.020125%
Front LoadN/A6%-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets4.78B83.5M5,725%
Annual Yield % from dividends3.076.5547%
Returns for 1 year3.882.79139%
Returns for 3 years14.8317.2086%
Returns for 5 years6.024.14145%
Returns for 10 years20.60N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPB32.870.76
+2.37%
Mid Penn Bancorp
CPRX31.27N/A
N/A
Catalyst Pharmaceuticals
BCDA0.90-0.03
-2.71%
BioCardia Inc.
TEAM109.10-6.85
-5.91%
Atlassian Corp
GALT2.42-0.19
-7.28%
Galectin Therapeutics